Third Rock Ventures III L.P. 13D and 13G filings for Voyager Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:19 pm Sale | 2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Third Rock Ventures III L.P. | 186,423 0.400% | -5,279,211 (-96.59%) | Filing |
| 2023-02-14 4:02 pm Sale | 2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Third Rock Ventures III L.P. | 5,465,634 14.200% | -3,953,663 (-41.97%) | Filing |